India’s Quizartinib FLT3 Inhibitor 17.7mg/26.5mg

So, Quizartinib is this FLT3 inhibitor that’s supposed to help AML patients who’ve tried other treatments and still have FLT3-ITD mutations. It works by stopping this FLT3 signaling thing, which is really important for leukemia cells to grow and survive. The tablets come in two strengths, 17.7 mg and 26.5 mg.

The usual starting dose, after a gradual start, is 53 mg a day. These tablets come in bottles with 28 in each. It’s a big deal for treating AML with FLT3 mutations, since it helps slow down the growth of those FLT3-positive leukemia cells.